Primary |
Hypertension |
36.7% |
Product Used For Unknown Indication |
24.9% |
Drug Use For Unknown Indication |
6.3% |
Atrial Fibrillation |
5.2% |
Blood Pressure Increased |
4.2% |
Type 2 Diabetes Mellitus |
2.9% |
Diabetes Mellitus |
2.3% |
Blood Pressure |
1.8% |
Depression |
1.8% |
Cardiovascular Disorder |
1.6% |
Cardiac Disorder |
1.5% |
Prophylaxis |
1.5% |
Angina Pectoris |
1.3% |
Arrhythmia |
1.3% |
Coronary Artery Disease |
1.3% |
Suicide Attempt |
1.2% |
Cardiac Failure |
1.2% |
Heart Rate Increased |
1.1% |
Blood Cholesterol |
1.0% |
Essential Hypertension |
1.0% |
|
Completed Suicide |
13.2% |
Syncope |
13.2% |
Bradycardia |
10.3% |
Hypotension |
8.6% |
Blood Pressure Increased |
4.7% |
Ventricular Tachycardia |
4.4% |
Medication Error |
4.2% |
Product Substitution Issue |
4.2% |
Suicidal Ideation |
4.2% |
Dizziness |
4.1% |
Palpitations |
3.7% |
Pharmaceutical Product Complaint |
3.4% |
Drug Ineffective |
3.1% |
Product Quality Issue |
2.9% |
Toxicity To Various Agents |
2.9% |
Therapeutic Response Unexpected With Drug Substitution |
2.7% |
Death |
2.5% |
Hypertension |
2.5% |
Vomiting |
2.5% |
Intentional Drug Misuse |
2.4% |
|
Secondary |
Hypertension |
24.6% |
Product Used For Unknown Indication |
24.5% |
Drug Use For Unknown Indication |
15.5% |
Atrial Fibrillation |
4.5% |
Diabetes Mellitus |
3.2% |
Depression |
2.8% |
Type 2 Diabetes Mellitus |
2.8% |
Cardiac Disorder |
2.7% |
Pain |
2.6% |
Blood Pressure Increased |
2.1% |
Angina Pectoris |
2.1% |
Suicide Attempt |
2.0% |
Blood Pressure |
1.8% |
Thyroid Disorder |
1.5% |
Blood Pressure Abnormal |
1.5% |
Cardiac Failure |
1.3% |
Thrombosis Prophylaxis |
1.2% |
Anxiety |
1.2% |
Blood Cholesterol Increased |
1.2% |
Intentional Overdose |
1.1% |
|
Completed Suicide |
17.6% |
Hypotension |
10.8% |
Syncope |
7.8% |
Drug Ineffective |
5.7% |
Somnolence |
4.7% |
Bradycardia |
4.5% |
Respiratory Arrest |
4.0% |
Death |
3.9% |
Suicide Attempt |
3.9% |
Angina Pectoris |
3.7% |
Vomiting |
3.7% |
Suicidal Ideation |
3.6% |
Poisoning |
3.4% |
Toxicity To Various Agents |
3.4% |
Dizziness |
3.2% |
Medication Error |
3.2% |
Myocardial Infarction |
3.2% |
Nausea |
3.2% |
Tremor |
3.2% |
Weight Decreased |
3.1% |
|
Concomitant |
Product Used For Unknown Indication |
31.2% |
Drug Use For Unknown Indication |
21.3% |
Hypertension |
12.8% |
Atrial Fibrillation |
4.0% |
Pain |
3.2% |
Diabetes Mellitus |
3.1% |
Rheumatoid Arthritis |
2.8% |
Blood Cholesterol Increased |
2.6% |
Prophylaxis |
2.2% |
Cardiac Disorder |
2.0% |
Multiple Myeloma |
2.0% |
Depression |
2.0% |
Type 2 Diabetes Mellitus |
1.8% |
Blood Pressure |
1.6% |
Gastrooesophageal Reflux Disease |
1.5% |
Osteoporosis |
1.4% |
Coronary Artery Disease |
1.3% |
Nuclear Magnetic Resonance Imaging |
1.2% |
Anxiety |
1.2% |
Chronic Obstructive Pulmonary Disease |
1.1% |
|
Vomiting |
12.6% |
Weight Decreased |
8.2% |
Myocardial Infarction |
6.7% |
Flushing |
6.4% |
Death |
6.2% |
Nausea |
5.3% |
Pain |
4.6% |
Pneumonia |
4.5% |
Dyspnoea |
4.3% |
Weight Increased |
4.3% |
Pruritus |
4.3% |
Drug Ineffective |
4.2% |
Urinary Tract Infection |
3.9% |
Thrombocytopenia |
3.9% |
Renal Failure Acute |
3.7% |
Pyrexia |
3.5% |
Rash |
3.4% |
Syncope |
3.4% |
Diarrhoea |
3.3% |
Oedema Peripheral |
3.3% |
|
Interacting |
Product Used For Unknown Indication |
18.9% |
Hypertension |
16.7% |
Coronary Artery Disease |
8.9% |
Atrial Fibrillation |
6.4% |
Dyslipidaemia |
6.0% |
Insomnia |
6.0% |
Depression |
4.6% |
Type 2 Diabetes Mellitus |
4.6% |
Tachycardia |
3.6% |
Anxiety |
3.2% |
Decreased Appetite |
3.2% |
Drug Use For Unknown Indication |
3.2% |
Hyperlipidaemia |
3.2% |
Prophylaxis Against Hiv Infection |
2.8% |
Arrhythmia |
1.4% |
Asthma |
1.4% |
Blood Cholesterol Increased |
1.4% |
Blood Pressure |
1.4% |
Bone Disorder |
1.4% |
Cardiac Failure |
1.4% |
|
Drug Interaction |
30.7% |
Glycosylated Haemoglobin Increased |
5.3% |
Renal Failure Acute |
5.3% |
Torsade De Pointes |
5.3% |
Alcohol Interaction |
4.0% |
Hyponatraemia |
4.0% |
Hypotension |
4.0% |
Sedation |
4.0% |
Syncope |
4.0% |
Transaminases Increased |
4.0% |
Ventricular Tachycardia |
4.0% |
Weight Increased |
4.0% |
Asthma |
2.7% |
Atrioventricular Block Complete |
2.7% |
Cognitive Disorder |
2.7% |
Headache |
2.7% |
Hepatic Enzyme Increased |
2.7% |
Hypertension |
2.7% |
Potentiating Drug Interaction |
2.7% |
Shock |
2.7% |
|